Latest Analgesic Stories
Arthritis sufferers may be able to do some legal shrooming and reduce their pain thanks to a “long-shot” series of experiments that are showing promising results.
Phase 1 study to include additional cohorts with novel product candidate being developed for the treatment of neuropathic pain NEW YORK, April 16, 2015 /PRNewswire/ -- Relmada Therapeutics,
Topical BioMedics is hosting its free monthly pain management webinar on Tuesday, April 14th, featuring the topic “The Role Diet & Hydration Play in Health & Wellness.” The webinar,
SALT LAKE CITY, April 8, 2015 /PRNewswire/ -- Phoenix PharmaLabs, Inc.
Programs encouraging appropriate use of painkillers could improve safety, reduce costs ST.
Cash Payment Resulting from First Commercial Sale of MOVANTIK(TM) (naloxegol) Tablets in the US SAN FRANCISCO, April 2, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced
In the news release, Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020, issued 01-Apr-2015 by Egalet Corporation over PR Newswire, we
WAYNE, Pa., April 1, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing
WILMINGTON, Del., March 31, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) reported that partner AstraZeneca announced today that MOVANTIK(TM) (naloxegol) has launched in the United States.
GIA announces the release of a comprehensive global report on Pain Management Devices.
- Emitting flashes of light; glittering.